Oscar Health Forecast, price target & analysts
Oscar Health Target price 2025 - Analyst rating & recommendation
Oscar Health Classifications & Recommendation:
Oscar Health Price Target
| Target Price | $19.56 |
| Price | $12.62 |
| Potential |
55.01%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Oscar Health 2026 .
The average Oscar Health target price is $19.56.
This is
55.01%
register free of charge
$28.00
121.87%
register free of charge
$12.00
4.91%
register free of charge
|
|
| A rating was issued by 8 analysts: 4 Analysts recommend Oscar Health to buy, 2 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Oscar Health stock has an average upside potential 2026 of
55.01%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 9.18 | 11.15 |
| 56.54% | 21.46% | |
| Net Margin | 0.27% | 1.44% |
| 105.24% | 427.59% |
8 Analysts have issued a sales forecast Oscar Health 2025 . The average Oscar Health sales estimate is
This results in the following potential growth metrics:
3 Oscar Health Analysts have issued a net profit forecast 2025. The average Oscar Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.10 | 0.64 |
| 108.20% | 540.00% | |
| P/E | 19.71 | |
| EV/Sales | 0.17 |
3 Analysts have issued a Oscar Health forecast for earnings per share. The average Oscar Health EPS is
This results in the following potential growth metrics and future valuations:
Current Oscar Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Dec 10 2024 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 13 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Dec 10 2024 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 07 2024 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 10 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
